Hydrea Capsule
Product Images NDC 80725-810

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrea (NDC 80725-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydrea 01)

Chemical Structure (Hydrea 01)
Chemical structure of Hydroxyurea showing its molecular framework with an amino group, carbonyl group, and hydroxyl group arrangement.*
FDA Label Image

Principal Display Panel (500 mg Bottle Label)

Principal Display Panel (500 mg Bottle Label)
Label for HYDREA 500 mg capsules, containing hydroxyurea, an oral prescription medication. The label shows the product name and strength prominently, cautions that it is a cytotoxic agent, and lists Waylis Therapeutics LLC as the labeler. The label includes a barcode, NDC 80725-810-10, and directions for safe handling and storage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.